Evaluation and Identification of Protein Blood Biomarkers for Alzheimerâs Disease:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Subject wise Global Events

Agri, Food & Aqua
Business & Management
Chemical Engineering
Chemistry
Dermatology
EEE & Engineering
Nutrition
Nanotechnology
Pharmaceutical Sciences

Evaluation and Identification of Protein Blood Biomarkers for Alzheimerâs Disease:

Alzheimer’s disease (AD) accounts for 80% of all dementia, but current treatment cannot provide definite cure. For this reason, researchers seek highly accurate preclinical biomarkers for minimal cognitive impairment.

Citation: Park J, Park JE, Lee J, Choi C (2014) Evaluation and Identification of Protein Blood Biomarkers for Alzheimerâ€™s Disease: A Systematic Review and Integrative Analysis. J Mol Biomark Diagn 5:190.